Vaxart Statistics
Share Statistics
Vaxart has 228.21M
shares outstanding. The number of shares has increased by 0.23%
in one year.
| Shares Outstanding | 228.21M |
| Shares Change (YoY) | 0.23% |
| Shares Change (QoQ) | 0.21% |
| Owned by Institutions (%) | 15.71% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 53 |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 12.05M, so 5.29% of the outstanding
shares have been sold short.
| Short Interest | 12.05M |
| Short % of Shares Out | 5.29% |
| Short % of Float | 5.34% |
| Short Ratio (days to cover) | 6.93 |
Valuation Ratios
The PE ratio is -19.99 and the forward
PE ratio is -0.96.
Vaxart's PEG ratio is
0.48.
| PE Ratio | -19.99 |
| Forward PE | -0.96 |
| PS Ratio | 46.63 |
| Forward PS | 3.5 |
| PB Ratio | 22.71 |
| P/FCF Ratio | -29.53 |
| PEG Ratio | 0.48 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Vaxart.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.75,
with a Debt / Equity ratio of 0.3.
| Current Ratio | 0.75 |
| Quick Ratio | 0.75 |
| Debt / Equity | 0.3 |
| Debt / EBITDA | -0.3 |
| Debt / FCF | -0.39 |
| Interest Coverage | -22.33 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $273,333.33 |
| Profits Per Employee | $-637,600 |
| Employee Count | 105 |
| Asset Turnover | 0.17 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 260K |
| Effective Tax Rate | -0.39% |
Stock Price Statistics
The stock price has increased by -57.65% in the
last 52 weeks. The beta is 1.28, so Vaxart's
price volatility has been higher than the market average.
| Beta | 1.28 |
| 52-Week Price Change | -57.65% |
| 50-Day Moving Average | 0.42 |
| 200-Day Moving Average | 0.65 |
| Relative Strength Index (RSI) | 48.69 |
| Average Volume (20 Days) | 2,018,455 |
Income Statement
In the last 12 months, Vaxart had revenue of 28.7M
and earned -66.95M
in profits. Earnings per share was -0.03.
| Revenue | 28.7M |
| Gross Profit | 24.3M |
| Operating Income | -66.29M |
| Net Income | -66.95M |
| EBITDA | -59.32M |
| EBIT | -63.72M |
| Earnings Per Share (EPS) | -0.03 |
Full Income StatementBalance Sheet
The company has 25.23M in cash and 17.53M in
debt, giving a net cash position of 7.7M.
| Cash & Cash Equivalents | 25.23M |
| Total Debt | 17.53M |
| Net Cash | 7.7M |
| Retained Earnings | -476.52M |
| Total Assets | 166.39M |
| Working Capital | -22.62M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -44.76M
and capital expenditures -554K, giving a free cash flow of -45.32M.
| Operating Cash Flow | -44.76M |
| Capital Expenditures | -554K |
| Free Cash Flow | -45.32M |
| FCF Per Share | -0.02 |
Full Cash Flow StatementMargins
Gross margin is 84.67%, with operating and profit margins of -230.99% and -233.27%.
| Gross Margin | 84.67% |
| Operating Margin | -230.99% |
| Pretax Margin | -232.36% |
| Profit Margin | -233.27% |
| EBITDA Margin | -206.69% |
| EBIT Margin | -230.99% |
| FCF Margin | -157.9% |
